Overview
Semax is a research-grade peptide compound that has attracted significant attention in the scientific community for its role in bioactive optimization. ACTH-derived neurotrophic compound. Elevates BDNF, enhances memory consolidation and cognitive resilience.
This compound belongs to the bioactive category of research peptides and has been the subject of numerous preclinical investigations. Its unique molecular properties make it a valuable tool for researchers exploring novel therapeutic pathways.
Semax (ACTH 4-7 analogue) upregulates BDNF and NGF expression in the hippocampus, enhancing synaptic plasticity and neuroprotection under stress conditions. The growing body of published literature continues to expand our understanding of this compound's potential applications in laboratory settings.
Mechanism of Action
Semax (ACTH 4-7 analogue) upregulates BDNF and NGF expression in the hippocampus, enhancing synaptic plasticity and neuroprotection under stress conditions.
The signaling pathways activated by Semax continue to be mapped through proteomic and transcriptomic analyses. Current research focuses on identifying the specific receptor subtypes and downstream effectors responsible for the observed biological responses. Understanding these molecular interactions is critical for advancing the compound from preclinical investigation toward potential translational applications.
Research Areas
- Growth hormone secretion pathway analysis
- Neurotrophic factor expression research
- Receptor binding kinetics
- Hormonal axis modulation
- Signal transduction research
Compound Specifications
| CAS Number | 80714-61-0 |
| Purity | ≥99% HPLC-MS verified |
| Storage | −20 °C. ≥12 months lyophilised. |
| Category | Bioactive |
| Price | €36 |
| Format | 5mg lyophilised |
Available Formats
- 1mg vial
- 5mg vial
Dissolution
Use our dilution calculator for precise concentration calculations.